We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NMRA Neumora Therapeutics Inc

0.51 (4.21%)
After Hours
Last Updated: 15:21:17
Delayed by 15 minutes


Draw Mode:

Volume 143,479
Bid Price 12.00
Ask Price 13.00
News -
Day High 12.16


52 Week Range


Day Low 11.6043
Share Name Share Symbol Market Stock Type
Neumora Therapeutics Inc NMRA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.51 4.21% 12.61 15:21:17
Open Price Low Price High Price Close Price Previous Close
12.10 11.6043 12.16 11.77 12.10
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
2,237 143,479 US$ 11.92 US$ 1,710,858 - 9.35 - 17.69
Last Trade Type Quantity Price Currency
15:21:16 95 US$ 12.79 USD

Neumora Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
US$ 1.93B - - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Neumora Therapeutics News

Date Time Source News Article
11/28/202315:21Edgar (US Regulatory)Form 8-K - Current report
11/27/202306:00GlobeNewswire Inc.Neumora Therapeutics Announces NMRA-266 IND Clearance and..
11/01/202315:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/01/202315:01Edgar (US Regulatory)Form 8-K - Current report
11/01/202306:00GlobeNewswire Inc.Neumora Therapeutics Reports Third Quarter 2023 Financial..
10/30/202306:00GlobeNewswire Inc.Neumora Therapeutics to Participate in Upcoming Conferences..
10/10/202306:00GlobeNewswire Inc.Neumora Therapeutics Announces Appointment of Robert Lenz,..
9/14/202319:49GlobeNewswire Inc.Neumora Therapeutics Announces Pricing of Initial Public..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No NMRA Message Board. Create One! See More Posts on NMRA Message Board See More Message Board Posts

Historical NMRA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week12.0212.999910.0012.06307,9110.594.91%
1 Month12.0912.999910.0011.76216,8680.524.3%
3 Months16.5017.699.3511.92345,888-3.89-23.58%
6 Months16.5017.699.3511.92345,888-3.89-23.58%
1 Year16.5017.699.3511.92345,888-3.89-23.58%
3 Years16.5017.699.3511.92345,888-3.89-23.58%
5 Years16.5017.699.3511.92345,888-3.89-23.58%

Neumora Therapeutics Description

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease; NMRA-266 for the treatment of schizophrenia and other neuropsychiatric disorders; NMRA-NMDA for the treatment of schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |